- Home
- RSSS vs CRBP Comparison
RSSS vs CRBP Comparison
Compare RSSS & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- CRBP
- Stock Information
- Founded
- RSSS 2006
- CRBP 2009
- Country
- RSSS United States
- CRBP United States
- Employees
- RSSS N/A
- CRBP N/A
- Industry
- RSSS Business Services
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- CRBP Health Care
- Exchange
- RSSS Nasdaq
- CRBP Nasdaq
- Market Cap
- RSSS 127.0M
- CRBP 114.8M
- IPO Year
- RSSS N/A
- CRBP N/A
- Fundamental
- Price
- RSSS $3.44
- CRBP $14.52
- Analyst Decision
- RSSS Strong Buy
- CRBP Strong Buy
- Analyst Count
- RSSS 1
- CRBP 8
- Target Price
- RSSS $5.00
- CRBP $50.57
- AVG Volume (30 Days)
- RSSS 192.9K
- CRBP 174.6K
- Earning Date
- RSSS 11-13-2025
- CRBP 11-06-2025
- Dividend Yield
- RSSS N/A
- CRBP N/A
- EPS Growth
- RSSS N/A
- CRBP N/A
- EPS
- RSSS 0.04
- CRBP N/A
- Revenue
- RSSS $49,057,981.00
- CRBP N/A
- Revenue This Year
- RSSS $5.79
- CRBP N/A
- Revenue Next Year
- RSSS $8.46
- CRBP $220.00
- P/E Ratio
- RSSS $86.25
- CRBP N/A
- Revenue Growth
- RSSS 9.94
- CRBP N/A
- 52 Week Low
- RSSS $2.32
- CRBP $4.64
- 52 Week High
- RSSS $4.24
- CRBP $20.77
- Technical
- Relative Strength Index (RSI)
- RSSS 49.57
- CRBP 81.02
- Support Level
- RSSS $3.49
- CRBP $10.20
- Resistance Level
- RSSS $3.78
- CRBP $15.00
- Average True Range (ATR)
- RSSS 0.22
- CRBP 0.76
- MACD
- RSSS -0.06
- CRBP 0.27
- Stochastic Oscillator
- RSSS 15.33
- CRBP 89.79
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.